VEGFA and gastric adenocarcinoma: Anti-HER-2 antibodies, anti-VEGF antibodies, tyrosine-kinase inhibitor (TKI), and immuno-checkpoint inhibitors (ICIs) have achieved preliminary results in the treatment of STAD.